Flint, S.W. orcid.org/0000-0003-4878-3019 (2024) Rethinking the label anti-obesity medication. The Lancet Diabetes & Endocrinology, 12 (5). pp. 301-302. ISSN 2213-8587
Metadata
| Item Type: | Article |
|---|---|
| Authors/Creators: |
|
| Copyright, Publisher and Additional Information: | © 2024 Elsevier Ltd. This is an author produced version of an article published in The Lancet Diabetes & Endocrinology. Uploaded in accordance with the publisher's self-archiving policy. |
| Dates: |
|
| Institution: | The University of Leeds |
| Academic Units: | The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Psychology (Leeds) |
| Depositing User: | Symplectic Publications |
| Date Deposited: | 21 Mar 2024 10:48 |
| Last Modified: | 23 Oct 2024 00:13 |
| Status: | Published |
| Publisher: | Elsevier |
| Identification Number: | 10.1016/S2213-8587(24)00071-8 |
| Open Archives Initiative ID (OAI ID): | oai:eprints.whiterose.ac.uk:210582 |

CORE (COnnecting REpositories)
CORE (COnnecting REpositories)